Van Roy F - Search Results

1

Tumor necrosis factor cytotoxicity is associated with phospholipase D activation.

De Valck D, Beyaert R, Van Roy F, Fiers W. De Valck D, et al. Among authors: van roy f. Eur J Biochem. 1993 Mar 1;212(2):491-7. doi: 10.1111/j.1432-1033.1993.tb17686.x. Eur J Biochem. 1993. PMID: 8444187 Free article.

2

Synergistic induction of interleukin-6 by tumor necrosis factor and lithium chloride in mice: possible role in the triggering and exacerbation of psoriasis by lithium treatment.

Beyaert R, Schulze-Osthoff K, Van Roy F, Fiers W. Beyaert R, et al. Among authors: van roy f. Eur J Immunol. 1992 Aug;22(8):2181-4. doi: 10.1002/eji.1830220835. Eur J Immunol. 1992. PMID: 1322305

3

Lithium chloride potentiates tumor necrosis factor-induced and interleukin 1-induced cytokine and cytokine receptor expression.

Beyaert R, Schulze-Osthoff K, Van Roy F, Fiers W. Beyaert R, et al. Among authors: van roy f. Cytokine. 1991 Jul;3(4):284-91. doi: 10.1016/1043-4666(91)90496-z. Cytokine. 1991. PMID: 1651781

4

Tumour-necrosis-factor-mediated cytotoxicity is correlated with phospholipase-A2 activity, but not with arachidonic acid release per se.

Suffys P, Beyaert R, De Valck D, Vanhaesebroeck B, Van Roy F, Fiers W. Suffys P, et al. Among authors: van roy f. Eur J Biochem. 1991 Jan 30;195(2):465-75. doi: 10.1111/j.1432-1033.1991.tb15727.x. Eur J Biochem. 1991. PMID: 1847684 Free article.

5

Induction of inflammatory cell infiltration and necrosis in normal mouse skin by the combined treatment of tumor necrosis factor and lithium chloride.

Beyaert R, De Potter C, Vanhaesebroeck B, Van Roy F, Fiers W. Beyaert R, et al. Among authors: van roy f. Am J Pathol. 1991 Mar;138(3):727-39. Am J Pathol. 1991. PMID: 1848044 Free PMC article.

6

Two discrete types of tumor necrosis factor-resistant cells derived from the same cell line.

Vanhaesebroeck B, Van Bladel S, Lenaerts A, Suffys P, Beyaert R, Lucas R, Van Roy F, Fiers W. Vanhaesebroeck B, et al. Among authors: van bladel s, van roy f. Cancer Res. 1991 May 1;51(9):2469-77. Cancer Res. 1991. PMID: 1849793

7

Expression of the tumor necrosis factor gene in tumor cells correlates with reduced tumorigenicity and reduced invasiveness in vivo.

Vanhaesebroeck B, Mareel M, Van Roy F, Grooten J, Fiers W. Vanhaesebroeck B, et al. Among authors: van roy f. Cancer Res. 1991 Apr 15;51(8):2229-38. Cancer Res. 1991. PMID: 2009541

8

Inhibition by glucocorticoids of tumor necrosis factor-mediated cytotoxicity. Evidence against lipocortin involvement.

Beyaert R, Suffys P, Van Roy F, Fiers W. Beyaert R, et al. Among authors: van roy f. FEBS Lett. 1990 Mar 12;262(1):93-6. doi: 10.1016/0014-5793(90)80161-b. FEBS Lett. 1990. PMID: 2138568 Free article.

9

Modulation of cellular susceptibility to the cytotoxic/cytostatic action of tumor necrosis factor by adenovirus E1 gene expression is cell type-dependent.

Vanhaesebroeck B, Timmers HT, Pronk GJ, van Roy F, Van der Eb AJ, Fiers W. Vanhaesebroeck B, et al. Among authors: van roy f, van der eb aj. Virology. 1990 Jun;176(2):362-8. doi: 10.1016/0042-6822(90)90006-d. Virology. 1990. PMID: 2140628

10

Cytotoxic activity of tumor necrosis factor is inhibited by amiloride derivatives without involvement of the Na+/H+ antiporter.

Vanhaesebroeck B, Cragoe EJ Jr, Pouysségur J, Beyaert R, Van Roy F, Fiers W. Vanhaesebroeck B, et al. Among authors: van roy f. FEBS Lett. 1990 Feb 26;261(2):319-22. doi: 10.1016/0014-5793(90)80581-3. FEBS Lett. 1990. PMID: 2155826 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters